Lataa...
The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.
OBJECTIVE: The transfer of abacavir, a new nucleoside inhibitor, and amprenavir, a new protease inhibitor, used for the treatment of human immunodeficiency virus, has been studied in the ex vivo human placental model. METHODS: The ex vivo human placental model used C14 antipyrine to determine the tr...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1998
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1784821/ https://ncbi.nlm.nih.gov/pubmed/9972485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/(SICI)1098-0997(1998)6:6<244::AID-IDOG4>3.0.CO;2-B |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|